Immunity, Cellular - Research News and Information

Saturday, January 10, 2009

Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination.

13 Nov 2008 NY-ESO-1 antigen is a prototype of a class of cancer/testis antigens. We carried out a clinical trial using NY-ESO-1 whole protein as a cancer vaccine for 13 advanced cancer patients. We have recently reported that vaccine elicited humoral and ... Read more...

Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy.

13 Oct 2008 BACKGROUND: We studied whether severely immunocompromised, human immunodeficiency virus (HIV)-infected children who were beginning highly active antiretroviral therapy (HAART) or changing HAART regimens could spontaneously respond to a recall ... Read more...

Differential pathways govern CD4+ CD28- T cell proinflammatory and effector responses in patients with coronary artery disease.

13 Oct 2008 Patients with acute coronary syndromes experience circulatory and intraplaque expansion of an aggressive and unusual CD4(+) lymphocyte subpopulation lacking the CD28 receptor. These CD4(+)CD28(-) cells produce IFN-gamma and perforin, and are ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Immunity, Cellular'

These are the very latest articles for this heading:

• Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination. 13 Nov 2008
• Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy. 13 Oct 2008
• Differential pathways govern CD4+ CD28- T cell proinflammatory and effector responses in patients with coronary artery disease. 13 Oct 2008
• Blimp-1 induced by IL-4 plays a critical role in suppressing IL-2 production in activated CD4 T cells. 13 Oct 2008
• XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma. 13 Oct 2008
• The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo. 13 Oct 2008
• Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. 13 Oct 2008
• Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis. 11 Oct 2008
• Challenges in the development of an HIV-1 vaccine. 30 Sep 2008
• Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases. 29 Sep 2008
• [Epithelial ovarian tumor microecology] 29 Sep 2008
• [Cellular immunotherapy for hematological malignancies] 29 Sep 2008
• Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus. 29 Sep 2008
• Role of inflammation in atherosclerosis associated with rheumatoid arthritis. 29 Sep 2008
• Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. 13 Sep 2008
• Role of MIF in inflammation and tumorigenesis. 13 Sep 2008
• Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness. 3 Sep 2008
• Etiology of sarcoidosis. 30 Aug 2008
• The immunology of sarcoidosis. 30 Aug 2008
• A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. 30 Aug 2008

See a longer list of these articles.

Technical information about 'Immunity, Cellular'

Definition: Those manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.

Descriptor UI: D007111

Alternative terms: Immunity, Cellular; Cellular Immunities; Cellular Immunity; Immunities, Cellular; Cell-Mediated Immunity; Cell Mediated Immunity; Cell-Mediated Immunities; Immunities, Cell-Mediated; Immunity, Cell-Mediated;

Related Mesh Headings: Hypersensitivity, Delayed;

Allowable Qualifiers: drug effects; genetics; immunology; physiology; radiation effects;

Tree Number: G12.450.555;

History Note: 72(70)

Technical Notes: IM general only, NIM with specific disease /immunol (IM): TN 242